However, despite the rapid scale-up of ART with support from both the United States President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund for AIDS Tuberculosis and Malaria (GFATM), and an increase in the ART eligibility threshold to CD4<350 cell/mm3 in 2011, nearly half of all PLHIV across the nation continue to present late and initiate ART with CD4 counts <100 cells/mm3[42]–[44]. The gene discussed is CD4; the disease is tuberculosis.